Solmux Broncho Suspension

Solmux Broncho Suspension

COMPOSITION

Each 5 mL ( 1 teaspoonful ) suspension contains:

Salbutamol……………………………………………..1 mg

Carbocisteine………………………………………125 mg

Excipients : Agar, Carboxymenthylcellclose Sodium, Sorbitol Solution, Glycerin, Sodium Benzoate, Sodium Hydroxide, FD&C Yellow # 6, Saccharin Sodium, Juicy Orange Flavour.

DOSAGE AND INSTRUCTION FOR USE

Orally, every 6-8 hours, or, as prescribed by a physician.

2-6 years…………………………………………………………….5 mL (1  teaspoonful)

7-12 years…………………………………………………………10 mL  (1 teaspoonfuls)

CONTRAINDICATIONS

Known hypersensitivity to any of the components of the product. Children under 2 years old.

PRECAUTIONS

Consult a doctor if:

• The cough persists for more than 3 weeks or if it gets worse.
• The cough is accompanied by a recurring fever.
• You experience upsets stomach or heartburn affer taking this product.
• You have any new or unusual symptoms.

SIDE-EFFECTS

Solmux Broncho is generally well-tolerated. Adverse effects of carbocisteine include skin raghes, nausea, headaches, myalgia, dizziness and urinary incontinence. Gastrointestinal disturbance often occurs with acute overdosage.

Salbutamol may cause tremor, palpitation, tachycardia. These effects are less observed in children. Tachycardia, digestive disturbance (nausea, vomiting) caused by high doses of salbutamo have been reported.

Please inform your  doctor of all undesirable effects upon  drug administration.

OVERDOSE AND TREATMENT

The symptoms of salbutamol overdosage may include malaise, headache, dizziness, nausea, nervousness, limb tremor, tachycardia, cardiac arrhythmia, blood pressure change, convulsion. Hypokalaemia also may occur. Treatment consists of discontinuation of oral salbutamol together with appropriate symptomatic therapy. In the event of serious poisoning, the stomach should be emptied, if necessary, a beta-blocker administered with caution in patients with a history of bronchospasm

DRUG INTERACTIONS

Concomitant administration with carbocisteine enhances the absorption of sodium amoxicillin. Pretreatment with Cimetidine severely impairs the urinacy elimination of carbocisteine sulfoxides. Concomitant intake of diuretics may enhance the hypokalemia that occurs with large doses of salbutamal. The effects of this drug are inhibited by beta-blocker.

PRESENTATION

Bottle of 60 mL

STORAGE

Store at temperatures not exceeding 30⁰C

SHELFLIFE

24 months

USE UPON DOCTOR’S PRESCRIPTION ONLY KEEP AWAY FROM CHILDREN READ THE PACKAGE INSERT CAREFULLY BEFORE USE FOR MORE INFORMATION, PLEASE ASK FOR DOCTOR’S ADVICE.

Write a review